Vanda Pharmaceuticals Inc. (VNDA) Institutional Ownership

Ownership Summary

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) showed up in the 13F filings of 146 institutional investors as of December 2025.

• These investors held 71.0% of outstanding shares in December 2025, down from 76.7% in September 2025.
• They increased total shares held in Vanda Pharmaceuticals by 2.65% from the prior quarter, while the number of investors in VNDA decreased 0.68% year over year.
• Of these 146 holders, 62 added to their stakes in Vanda Pharmaceuticals, 63 trimmed positions, and 21 made no changes.
• The aggregate institutional position in Vanda Pharmaceuticals amounted to 41.87Mn shares as of December 2025, up by 1.08Mn shares quarter on quarter, and down 3.02Mn shares year over year.
• BlackRock, Inc. is the top holder of Vanda Pharmaceuticals as of December 31, 2025, with 7.28Mn shares representing 12.35% of outstanding stock.
• The biggest buyers of Vanda Pharmaceuticals for the quarter ending December 2025 included VANGUARD CAPITAL MANAGEMENT LLC (2.48Mn), State Street Corp (1.75Mn), VANGUARD PORTFOLIO MANAGEMENT LLC (1.01Mn), AQR CAPITAL MANAGEMENT LLC (976.57K), AIGH Capital Management LLC (751.57K).
• The largest sales of VNDA for the quarter ending December 2025 came from ACADIAN ASSET MANAGEMENT LLC (614.82K), BlackRock, Inc. (497.55K), Connor, Clark & Lunn Investment Management Ltd. (366.69K), DIMENSIONAL FUND ADVISORS LP (346.84K), Jump Financial, LLC (274.93K).
• According to Business Quant data, leading holders of VNDA for December 2025 are BlackRock, Inc. (7.28Mn), RENAISSANCE TECHNOLOGIES LLC (3.76Mn), State Street Corp (3.02Mn), AIGH Capital Management LLC (2.75Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.48Mn), MILLENNIUM MANAGEMENT LLC (1.88Mn), ACADIAN ASSET MANAGEMENT LLC (1.8Mn), DIMENSIONAL FUND ADVISORS LP (1.77Mn), AQR CAPITAL MANAGEMENT LLC (1.6Mn), GEODE CAPITAL MANAGEMENT, LLC (1.44Mn).